Fara
Non-Profit & Charitable Organizations · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
533 W Uwchlan Ave Ste 202, Downingtown, ...Phone Number
(484) 879-6160Website
www.curefa.orgRevenue
$7 MillionIndustry
About Fara
Fara Org Chart
Is Fara your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Fara had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Fara has new funding data
Fara, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Fara recently announced quarterly report
Check out if Fara is spiking on competitors!
Check if Fara has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Fara launches new products
Congratulate Masked Content for being promoted to Masked Content at Fara
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Fara
Compare insights from companies similar to Fara, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fara is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Fara is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Fara.
Fara financials insights
Gather financial insights about Fara, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$150K
Debt
$77K
Fara Tech Stack
A closer look at the technologies used by Fara
Most Recent Scoops
Fara News & Media
Larimar Therapeutics, Inc. (LRMR) Discusses On The Nomlabofusp Program For The Treatment Of Friedreich's Ataxia Conference Call (Transcript)
Larimar Therapeutics reports positive data for nomlabofusp in Friedreich's ataxiaSolid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting the CNS and cardiac manifestations of Friedreich’s ataxia -Stealth BioTherapeutics Awarded Grant from Friedreich's Ataxia Research Alliance to Develop Investigational Mitochondrial Therapeutic SBT-589 for Friedreich's Ataxia
NEEDHAM, Mass., Sept. 11, 2024 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction and the...The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programmes to Develop New Therapies for Friedreich's Ataxia
OXFORD, United Kingdom and CLEVELAND, May 17, 2024 /PRNewswire/ -- The Oxford-Harrington Rare Disease Centre ('OHC'), a partnership (between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio) aimed at driving cutting-edge rare disease...
Top Non-Profit & Charitable Organizations Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fara
Friedreich's Ataxia Research Alliance (FARA) is a nonprofit organization focused on curing Friedreich's ataxia through funding research, supporting clinical trials, and fostering a global community. The organization provides grants for research initiatives and collaborates with the FA research community to develop new treatments. FARA also offers r... Read More
